Unknown OBSERVATIONAL NCT05201365

A Prospective Cohort Study of Compound Nanxing Zhitong Ointment

A Prospective Cohort Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Musculoskeletal Pain

Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd

Updated 4 times since 2022 Last updated: Jan 15, 2022 Started: Jan 31, 2022 Primary completion: Jan 31, 2023 Completion: Jan 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Musculoskeletal Pain, this trial is ongoing. The trial is conducted by Jiangsu Kanion Pharmaceutical Co., Ltd and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Feb 2022 — Feb 2024 [monthly]

Not Yet Recruiting

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Kanion Pharmaceutical Co., Ltd

Data source: Jiangsu Kanion Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.